COMPOSITION COMPRISING XANOMELINE AND TROSPIUM FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium. L'invention concerne une composition pharmaceutique orale, comp...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
10.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.
L'invention concerne une composition pharmaceutique orale, comprenant une pluralité de billes de xanoméline ayant un noyau comprenant de la xanoméline ou un sel de celle-ci; et une pluralité de billes de trospium ayant un noyau comprenant un sel de trospium. |
---|---|
Bibliography: | Application Number: CA20193114623 |